Cartesian Therapeutics Plummets Despite ‘Watershed Moment’ For CAR-T Drugs

Cartesian Therapeutics reported a “watershed moment” for its autoimmune-disease drug on Tuesday, but the biotech stock plunged.
The post Cartesian Therapeutics Plummets Despite 'Watershed Moment' For CAR-T Drugs appeared first on Investor&#03…